메뉴 건너뛰기




Volumn 39, Issue 3, 2012, Pages 271-272

Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: Combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; DORIPENEM; FOSFOMYCIN; IMIPENEM; MEROPENEM;

EID: 84857055605     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.11.012     Document Type: Letter
Times cited : (46)

References (5)
  • 1
    • 67749090915 scopus 로고    scopus 로고
    • Antimicrobial resistance among and therapeutic options against Gram-negative pathogens
    • J.J. Rahal Antimicrobial resistance among and therapeutic options against Gram-negative pathogens Clin Infect Dis 49 Suppl. 1 2009 S4 S10
    • (2009) Clin Infect Dis , vol.49 , Issue.SUPPL. 1
    • Rahal, J.J.1
  • 2
    • 78649883138 scopus 로고    scopus 로고
    • Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia
    • A. Apisarnthanarak, and L.M. Mundy Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia Clin Infect Dis 51 2010 1352 1354
    • (2010) Clin Infect Dis , vol.51 , pp. 1352-1354
    • Apisarnthanarak, A.1    Mundy, L.M.2
  • 3
    • 0023821657 scopus 로고
    • CDC definitions for nosocomial infections, 1988
    • [Erratum: Am J Infect Control 1988;16:177]
    • J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 1988 128 140 [Erratum: Am J Infect Control 1988;16:177]
    • (1988) Am J Infect Control , vol.16 , pp. 128-140
    • Garner, J.S.1    Jarvis, W.R.2    Emori, T.G.3    Horan, T.C.4    Hughes, J.M.5
  • 5
    • 84963042043 scopus 로고
    • Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the US Food and Drug Administration
    • A.W. Chow, C.B. Hall, J.O. Klein, R.B. Kammer, R.D. Meyer, and J.S. Remington Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the US Food and Drug Administration Clin Infect Dis 15 Suppl. 1 1992 S62 S88
    • (1992) Clin Infect Dis , vol.15 , Issue.SUPPL. 1
    • Chow, A.W.1    Hall, C.B.2    Klein, J.O.3    Kammer, R.B.4    Meyer, R.D.5    Remington, J.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.